Amprion and Modality.AI have formed a collaboration to explore the combined use of molecular biomarkers and artificial ...
Amprion, a global leader advancing diagnosis of neurodegenerative disorders through seed amplification testing, and Modality.AI, a leader in AI-enabled multimodal clinical assessments, today announced ...
PORTLAND, Ore., June 18, 2025--(BUSINESS WIRE)--Diabetomics has been rebranded Modality Dx. Founded by Dr. Srinivasa Nagalla, Modality Dx is an innovator in rapid test technologies for risk assessment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results